Presentation TCT 2016 Recognition of the Importance of On-Label Use and Appropriate Device Selection in EVAR Presenter: D. Christopher Metzger, Peter A. Schneider, Barry T. Katzen November 01, 2016
Presentation TCT 2016 Low-Profile Devices Have Expanded Treatment Options for Patients Undergoing EVAR Presenter: D. Christopher Metzger, Peter A. Schneider, Ehrin J. Armstrong November 01, 2016
Presentation TCT 2016 Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations Presenter: Neil E. Moat, John G. Webb, Philippe Généreux October 31, 2016
Presentation TCT 2016 Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors Presenter: Neil E. Moat, John G. Webb, Ian T. Meredith October 31, 2016
Presentation TCT 2016 Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR Presenter: Neil E. Moat, John G. Webb, Marina Urena October 31, 2016
Presentation TCT 2016 Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific Presenter: Neil E. Moat, John G. Webb, Samir R. Kapadia October 31, 2016
Presentation TCT 2016 Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC Presenter: Neil E. Moat, John G. Webb, Alexandra J. Lansky October 31, 2016
Presentation TCT 2016 The Landscape of Alternative Access Strategies for TAVR (Apical, Direct Aorta, Subclavian, Carotid, and Caval) Presenter: Neil E. Moat, John G. Webb, Adam B. Greenbaum October 31, 2016
Presentation TCT 2016 Complications 2. How to Prevent and Treat Transfemoral Access Site Complications Presenter: Neil E. Moat, John G. Webb, Stephen R. Ramee October 31, 2016
Presentation TCT 2016 TCT 1540: Successful PCI for Acute LAD Occlusion Due to Balloon Rupture Following Aortic Valvuloplasty Presenter: Jean-Claude Laborde, Thomas Walther, Jalal Zamani October 31, 2016
Presentation TCT 2016 TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Firas Zahr October 31, 2016
Presentation TCT 2016 The ELECT Trial: A Randomized Evaluation of Periprosthetic Regurgitation After TAVI With Sapien 3 or CoreValve Using Mulit-Modality Imaging Presenter: Neil E. Moat, John G. Webb, Pieter R. Stella October 31, 2016
Presentation TCT 2016 Von Willebrand Factor Multimers During TAVR: Implications for Treatment of Para-Valvular Regurgitation Presenter: Neil E. Moat, John G. Webb, Eric Van Belle October 31, 2016
Presentation TCT 2016 TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder Presenter: David R. Holmes Jr., Clifford J. Kavinsky, shantanu Deshpande October 31, 2016
Presentation TCT 2016 TCT 1515: The Dance of the Corevalve Presenter: Jean-Claude Laborde, Thomas Walther, Smriti Saraf October 31, 2016
Presentation TCT 2016 A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR Presenter: Neil E. Moat, John G. Webb, Scott Lim October 31, 2016
Presentation TCT 2016 PARTNER 2 and SAPIEN 3 Critique: Pros and Cons Presenter: William A. Gray, Stephan Windecker October 31, 2016
Presentation TCT 2016 Complications 1. Para-Valvular Regurgitation: Should Mild Para-Valvular Regurgitation After TAVR Be Treated? Presenter: Neil E. Moat, John G. Webb, Jeffrey J. Popma October 31, 2016
Presentation TCT 2016 TCT 1497:First Case of Transcatheter Aortic and Mitral Valve Replacements Presenter: Jean-Claude Laborde, Thomas Walther, Hellmuth Weich October 31, 2016
Presentation TCT 2016 TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time Presenter: David R. Holmes Jr., Clifford J. Kavinsky, M. Rizwan Sardar October 31, 2016